SONA Share Price | Sona Nanotech, Inc. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

48.12 k

Shareholding (Oct 2014)

FII

0.02%

Held by 1 FIIs

DII

99.98%

Held by 0 DIIs

Promoter

0.00%

Compare Sona Nanotech, Inc. with Similar Stocks

Royal Helium Ltd.Aduro Clean Technologies, Inc.International Battery Metals Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Specialty Chemicals

Market cap

CAD 36 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.28

Return on Equity

311.73%

Price to Book

-36.20

Revenue and Profits:

Net Sales:

(Quarterly Results - Jan 2026)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

1.67%

6 Months

22.0%

1 Year

5.17%

2 Years

-1.61%

3 Years

258.82%

4 Years

-70.1%

5 Years

-91.57%

Sona Nanotech, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

10.22%

EBIT to Interest (avg)

-4.37

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.31

Sales to Capital Employed (avg)

Tax Ratio

4.18%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-53.10

EV to EBIT

-15.54

EV to EBITDA

-19.67

EV to Capital Employed

53.28

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-342.84%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Oct 2014

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.02%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jan'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jan 2026 is 0.00% vs 0.00% in Jan 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jan 2026 is 22.22% vs -12.50% in Jan 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jan'26",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.50",
          "val2": "-0.70",
          "chgp": "28.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.70",
          "val2": "-0.90",
          "chgp": "22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Oct'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Oct 2025 is 0.00% vs 0.00% in Oct 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Oct 2025 is -22.22% vs -8.00% in Oct 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Oct'25",
        "Oct'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.70",
          "val2": "-2.20",
          "chgp": "-22.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.30",
          "val2": "-2.70",
          "chgp": "-22.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jan'26 - YoY

Jan'26

Jan'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.50

-0.70

28.57%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.70

-0.90

22.22%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jan 2026 is 0.00% vs 0.00% in Jan 2025

Consolidated Net Profit

YoY Growth in quarter ended Jan 2026 is 22.22% vs -12.50% in Jan 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Oct'25

Oct'25

Oct'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-2.70

-2.20

-22.73%

Interest

0.00

Exceptional Items

0.10

0.20

-50.00%

Consolidate Net Profit

-3.30

-2.70

-22.22%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Oct 2025 is 0.00% vs 0.00% in Oct 2024

Consolidated Net Profit

YoY Growth in year ended Oct 2025 is -22.22% vs -8.00% in Oct 2024

All Annual Results

Company CV

About Sona Nanotech, Inc.

Sona Nanotech, Inc.

Specialty Chemicals

Sona Nanotech Inc. is a nanotechnology life sciences company. The principal business is the development and application of its technology for use in multiplex diagnostic testing platforms. The Company offers a suite of products and services for multiple applications, including custom conjugation, lateral flow test development, lateral flow test production, point of care diagnostics, drug delivery, photo-thermal therapy and cell imaging. The Company’s products include Lateral flow. Its Lateral flow is a technology and a paper-based diagnostic test used to confirm the presence or absence of a target analyte in a sample without the need for specialist lab equipment. Lateral flow tests are used in various sectors, which include animal and veterinary health, food and drink, environmental testing, agricultural testing, and drugs of abuse.

Company Coordinates

Company Details

Purdy's Wharf Tower 2, 1969 Upper Water St Suite 2001 HALIFAX NS : B3J 3R7

Tel: 1 902 4821240

https://www.sonanano.com/

Registrar Details